Nimbus Therapeutics is a biotechnology company that develops small molecule therapies for a variety of diseases. The company was founded in 2009 by Bruce Booth and Jeb Keiper. Nimbus Therapeutics is headquartered in Cambridge, Massachusetts and has partnerships with several major pharmaceutical companies. The company's platform uses computational chemistry to design and develop small molecule drugs. Nimbus Therapeutics is focused on developing therapies for cancer, immunology, and metabolic diseases.